Evolution over a 15-year period of the clinical characteristics and outcomes of critically ill patients with severe community-acquired pneumonia

Medicina Intensiva

Volumn 40, Issue 4, 2016, Pages 238-245

  Valles J ^a,b,c   Diaz, E ^a   Martin Loeches I ^c,d   Bacelar, N ^a   Saludes, P ^a   Lema, J ^a   Gallego, M ^a   Fontanals, D ^a,b   Artigas, A ^a,b,c  

^a HOSPITAL DE SABADELL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

Bacteremia; Community acquired pneumonia; Critically ill patient; ICU; Mechanical ventilation; Shock

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PROGNOSIS; RETROSPECTIVE STUDY; SEVERE COMMUNITY ACQUIRED PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; BACTEREMIA; BACTERIAL PNEUMONIA; COMMUNITY ACQUIRED INFECTION; COMORBIDITY; COMPARATIVE STUDY; CRITICAL ILLNESS; HOSPITAL MORTALITY; MICROBIOLOGY; MIDDLE AGED; MORBIDITY; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICS AND NUMERICAL DATA; TRENDS; UNIVERSITY HOSPITAL;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MORBIDITY; PNEUMONIA, BACTERIAL; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84942028511     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2015.07.005     Document Type: Article

References (31)

1. Kozak L.J., Owings M.F., Hall M.J. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat 2005, 13:1-199.
2. Kung H.C., Hoyert D.L., Xu J.Q., Murphy S.L. Deaths final data for 2005: national vital statistics reports 2008, vol. 56. National Center for Health Statistics, Hyattsville, MD.
3. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
4. Restrepo M.I., Mortensen E.M., Velez J.A., Frei C., Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 2008, 133:610-617.
5. Pascual F.E., Matthay M.A., Bachetti P., Wachter R.M. Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest 2000, 117:503-512.
6. Wilson P.A., Ferguson J. Severe community-acquired pneumonia: an Australian perspective. Intern Med J 2005, 35:699-705.
7. Fine M.J., Smith M.A., Carson C.A., Mutha S.S., Sankey S.S., Weissfeld L.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. J Am Med Assoc 1996, 275:134-141.
8. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Disease Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
9. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I., et al. BTS guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl. 3):iii1-iii55.
10. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308.
11. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2012. Intensive Care Med 2013, 39:165-228.
12. Rello J., Bodí M., Mariscal D., Navarro M., Diaz E., Gallego M., et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2013, 123:174-180.
13. Sligl W.I., Marrie T.J. Severe community-acquired pneumonia. Crit Care Clin 2013, 29:563-601.
14. Fry A.M., Shay D.K., Holman R.C., Cums A.T., Anderson L.J. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. J Am Med Assoc 2005, 294:2712-2719.
15. Hebert P.L., McBean A.M., Kane R.L. Explaining trends in hospitalizations for pneumonia and influenza in the elderly. Med Care Res Rev 2005, 62:560-582.
16. Thomsen R.W., Riis A., Norgaard M., Jacobsen J., Christensen S., McDonald C.J., et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med 2006, 259:410-417.
17. Oosterheert J.J., Bonten M.J., Hak E., Lammers J.W., Schneider M.M., Hoepelman I.M. The increase in pneumonia-related morbidity and mortality among adults in the Netherlands and possible explanations for it. Ned Tijdschr Geneeskd 2004, 148:1765-1769. [in Dutch].
18. Woodhead M., Welch C.A., Harrison D.A., Bellingan G., Ayres J.G. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Crit Care 2006, 10(Suppl. 2):S1.
19. Viasus D., Di Yacovo S., García-Vidal C., et al. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore) 2013, 92:51-60.
20. Wiemkem T., Peyrani P., Bryant K., Kelley R.R., Summersgill J., Arnold F., et al. Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project. Eur J Clin Microbiol Infect Dis 2013, 32:705-710.
21. Choi S.H., Hong S.B., Ko G.B., Lee Y., Park H.J., Park S.Y., et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012, 186:325-332.
22. Mangtani P., Cutts F., Hall A.J. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis 2003, 3:71-78.
23. Jackson L.A., Neuzil K.M., Yu O., Benson P., Barlow W.E., Adams A.L., et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003, 348:1747-1755.
24. Dominguez A., Salleras L., Fedson D.S., Izquierdo C., Ruiz L., Ciruela P., et al. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study. Clin Infect Dis 2005, 40:1250-1257.
25. Gattarello S., Borgatta B., Solé-Violán J., Vallés J., Vidaur L., Zaragoza R., et al. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013). Chest 2014, 146:22-31.
26. American Thoracic Society, Infectious Disease Society of American Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
27. Waterer G.W., Somes G.W., Wunderink R.G. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001, 161:1837-1842.
28. Baddour L.M., Yu V.L., Klugman K.P., Feldman C., Ortqvist A., Rello J., et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004, 170:440-444.
29. Bordón J., Peyrani P., Brock G.N., Blasi F., Rello J., File T., et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008, 133:618-624.
30. Musher D.M., Alexandraki I., Graviss E.A., Yanbeiy N., Eid A., Inderias L.A., et al. Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study. Medicine (Baltimore) 2000, 79:210-221.
31. Vallés J., Martin-Loeches I., Torres A., Diaz E., Seijas I., López M.J., et al. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med 2014, 40:572-581.